1. Inicio
  2. Proyectos y Estudios
  3. Multicenter, open-label study to evaluate the safety, tolerability, pharmacokinetics, and efficacy of filgotinib in children and adolescents from 8 years to less than 18 years of age with polyarticular-course juvenile idiopathic arthritis.

Multicenter, open-label study to evaluate the safety, tolerability, pharmacokinetics, and efficacy of filgotinib in children and adolescents from 8 years to less than 18 years of age with polyarticular-course juvenile idiopathic arthritis.

Datos básicos

ENSAYO CLÍNICO INTERNACIONAL Finan. Competitiva Privada GLPG0634-CL-329 HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE Año de incio: 2026

Documentos

  • No hay documentos

Participantes

Grupos

Financiadores - Promotores

ALFASIGMA S.P.A.

Cita

Compartir